78 related articles for article (PubMed ID: 20223602)
1. Covert drug dependence should be the null hypothesis for explaining drug-withdrawal-induced clinical deterioration: the necessity for placebo versus drug withdrawal trials on normal control subjects.
Charlton BG
Med Hypotheses; 2010 May; 74(5):761-3. PubMed ID: 20223602
[TBL] [Abstract][Full Text] [Related]
2. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
3. [Controlled randomized clinical trials].
Jaillon P
Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine.
Cowan DT; Wilson-Barnett J; Griffiths P; Vaughan DJ; Gondhia A; Allan LG
Pain Med; 2005; 6(2):113-21. PubMed ID: 15773875
[TBL] [Abstract][Full Text] [Related]
5. Alcohol withdrawal syndrome: how to predict, prevent, diagnose and treat it.
Prescrire Int; 2007 Feb; 16(87):24-31. PubMed ID: 17323538
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
Lemoine P; Touchon J; Billardon M
Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of and physiological responses to nitrous oxide gas treatment during alcohol withdrawal: a double-blind, placebo-controlled trial.
Alho H; Methuen T; Paloheimo M; Strid N; Seppä K; Tiainen J; Salaspuro M; Roine R
Alcohol Clin Exp Res; 2002 Dec; 26(12):1816-22. PubMed ID: 12500105
[TBL] [Abstract][Full Text] [Related]
8. Oxcarbazepine--efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot study.
Koethe D; Juelicher A; Nolden BM; Braunwarth WD; Klosterkötter J; Niklewski G; Wodarz N; Klatt J; Burtscheidt W; Gaebel W; Markus Leweke F
Alcohol Clin Exp Res; 2007 Jul; 31(7):1188-94. PubMed ID: 17511748
[TBL] [Abstract][Full Text] [Related]
9. Calcium channel blocking drugs in the management of drug dependence, withdrawal and craving. A clinical pilot study with nifedipine and verapamil.
Shulman A; Jagoda J; Laycock G; Kelly H
Aust Fam Physician; 1998 Jan; 27 Suppl 1():S19-24. PubMed ID: 9503731
[TBL] [Abstract][Full Text] [Related]
10. Polysomnography during withdrawal with clomethiazole or placebo in alcohol dependent patients--a double-blind and randomized study.
Gann H; Feige B; Cloot O; Van Wasen H; Zinzgraf D; Hohagen F; Riemann D
Pharmacopsychiatry; 2004 Sep; 37(5):228-35. PubMed ID: 15359376
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy of alcohol-withdrawal syndrome in hospitalised patients. Clinical and methodological aspects.
Busch H; Frings A
Pharmacopsychiatry; 1988 Sep; 21(5):232-7. PubMed ID: 3067245
[TBL] [Abstract][Full Text] [Related]
12. Sleep complaints: Whenever possible, avoid the use of sleeping pills.
Prescrire Int; 2008 Oct; 17(97):206-12. PubMed ID: 19536941
[TBL] [Abstract][Full Text] [Related]
13. Effect of buspirone on withdrawal symptoms associated with smoking cessation.
Hilleman DE; Mohiuddin SM; Del Core MG; Sketch MH
Arch Intern Med; 1992 Feb; 152(2):350-2. PubMed ID: 1739365
[TBL] [Abstract][Full Text] [Related]
14. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
Reoux JP; Saxon AJ; Malte CA; Baer JS; Sloan KL
Alcohol Clin Exp Res; 2001 Sep; 25(9):1324-9. PubMed ID: 11584152
[TBL] [Abstract][Full Text] [Related]
15. On the adverse reactions and efficacy of long-term treatment with flupirtine: preliminary results of an ongoing twelve-month study with 200 patients suffering from chronic pain states in arthrosis or arthritis.
Herrmann WM; Kern U; Aigner M
Postgrad Med J; 1987; 63 Suppl 3():87-103. PubMed ID: 2451818
[TBL] [Abstract][Full Text] [Related]
16. [New anxiolytic drugs: methodological issues].
Ginestet D; Corruble E
Encephale; 1993; 19(6):627-37. PubMed ID: 12404782
[TBL] [Abstract][Full Text] [Related]
17. Safety of ipsapirone treatment compared with lorazepam: discontinuation effects.
Busto UE; Naranjo CA; Bremner KE; Peachey JE; Bologa M
J Psychiatry Neurosci; 1998 Jan; 23(1):35-44. PubMed ID: 9505058
[TBL] [Abstract][Full Text] [Related]
18. Carbamazepine versus oxazepam in the treatment of alcohol withdrawal: a double-blind study.
Stuppaeck CH; Pycha R; Miller C; Whitworth AB; Oberbauer H; Fleischhacker WW
Alcohol Alcohol; 1992 Mar; 27(2):153-8. PubMed ID: 1524606
[TBL] [Abstract][Full Text] [Related]
19. The effect of mianserin add-on, on the intensity of opioid withdrawal symptoms during detoxification program--a randomized, double blind, placebo controlled, prospective study.
Herman I; Shamir D; Bar-Hamburger R; Pick CG; Schreiber S
Addict Behav; 2005 Jul; 30(6):1154-67. PubMed ID: 15925125
[TBL] [Abstract][Full Text] [Related]
20. [alpha-beta L-aspartate magnesium in treatment of chronic benzodiazepine abuse: controlled and double-blind study versus placebo].
Hantouche EG; Guelfi JD; Comet D
Encephale; 1998; 24(5):469-79. PubMed ID: 9850822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
